A phase 3 study of androgen annihilation in high-risk biochemically relapsed prostate cancer: An Alliance Foundation trial (AFT-19) Meeting Abstract
| Authors: | Aggarwal, R. R.; Eggener, S. E.; Chen, R. C.; Heller, G.; Patnaik, A.; Xiao, H.; Weckstein, D.; Mohler, J.; Watson, M.; Taplin, M. E.; Skoog-Sluman, L. A.; Pereji, M.; Aikins-Afful, E.; Parsons, J. K.; Ryan, C. J.; Morris, M. J. |
| Abstract Title: | A phase 3 study of androgen annihilation in high-risk biochemically relapsed prostate cancer: An Alliance Foundation trial (AFT-19) |
| Meeting Title: | 54th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 36 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2018 Jun 1-5 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2018-05-20 |
| Start Page: | 290s |
| Language: | English |
| ACCESSION: | WOS:000442916007665 |
| DOI: | 10.1200/JCO.2018.36.15_suppl.TPS5090 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: TPS5090 -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
